1. Home
  2. INUV vs NSRX Comparison

INUV vs NSRX Comparison

Compare INUV & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inuvo Inc.

INUV

Inuvo Inc.

HOLD

Current Price

$1.86

Market Cap

28.3M

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$2.25

Market Cap

25.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INUV
NSRX
Founded
N/A
2019
Country
United States
Israel
Employees
N/A
7
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.3M
25.8M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
INUV
NSRX
Price
$1.86
$2.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$11.00
$19.67
AVG Volume (30 Days)
217.9K
176.1K
Earning Date
05-08-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
50.00
N/A
EPS
N/A
N/A
Revenue
$86,209,305.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.65
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.88
N/A
52 Week Low
$0.34
$1.98
52 Week High
$6.27
$9.99

Technical Indicators

Market Signals
Indicator
INUV
NSRX
Relative Strength Index (RSI) 39.01 36.03
Support Level $1.83 $1.98
Resistance Level $1.99 $5.20
Average True Range (ATR) 0.16 0.22
MACD -0.02 0.10
Stochastic Oscillator 13.73 40.85

Price Performance

Historical Comparison
INUV
NSRX

About INUV Inuvo Inc.

Inuvo Inc is an advertising technology and services company that has developed and commercialized large language generative artificial intelligence (AI) for modeling media audiences. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: